|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-05
|
$721,537
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
|
5R01CA195519-03
|
$238,425
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
|
1R01CA228465-01
|
$404,275
|
ZENG, DEFU
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN
|
5R01CA181050-05
|
$291,828
|
PULSIPHER, MICHAEL
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Highly Sensitive Chimerism Testing to Detect Early Leukemia Relapse Post-Allo-Transplantation
|
1R41CA232805-01
|
$173,566
|
KANAAN, SAMI
|
CHIMEROCYTE, INC.
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-04
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-14
|
$1,630,446
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S2
|
$59,495
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S3
|
$62,500
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S4
|
$149,528
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S5
|
$60,691
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-05
|
$127,865
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S1
|
$59,375
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S2
|
$249,377
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S3
|
$84,682
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S4
|
$119,106
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-44
|
$5,679,062
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Ionizing radiation promotes clonal expansion of premalignant cells in the thymus
|
4R00CA212198-03
|
$248,999
|
LEE, CHANG LUNG
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-10
|
$357,750
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-05
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-40
|
$250,143
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Investigating the role of interleukin-22 in thymus function
|
5R00CA176376-04
|
$245,184
|
DUDAKOV, JARROD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S1
|
$78,024
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S2
|
$199,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S3
|
$246,630
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S4
|
$225,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S5
|
$33,324
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-43
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML
|
5K01CA188151-04
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
2R01CA100019-16
|
$376,200
|
PETERSDORF, EFFIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Immuno and Epigenetics of Hematopoietic Cell Transplantation
|
5R01CA218285-02
|
$630,020
|
PETERSDORF, EFFIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Understanding and predicting relapse in acute myeloid leukemia
|
2R01CA175008-06
|
$418,000
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-10
|
$560,424
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality
|
1R01CA227092-01
|
$784,196
|
SORROR, MOHAMED
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-20
|
$892,086
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|